Prospective phase II study of tumor response assessment by CT and FDG-PET/CT following 8 weekly doses of cetuximab in patients with metastatic/recurrent head and neck squamous cell carcinoma (HNSCC).

被引：0
|
作者：
Ley, J. [1 ]
Siegel, B. A. [1 ]
Dehdashti, F. [1 ]
Subramanian, J. [1 ]
Ansstas, G. [1 ]
Rachocki, T. [1 ]
Mathai, J. [1 ]
Wildes, T. M. [1 ]
Kuperman, D. I. [1 ]
Adkins, D. [1 ]
机构：
[1] Washington Univ, Sch Med, St Louis, MO USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.5569
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5569
引用
收藏
页数：1
相关论文
共 50 条
  • [31] The role of F-18 FDG-PET/CT for surveillance in patients with head and neck squamous cell carcinoma
    Kim, Hyoungwoo
    Yoo, Ie Ryung
    Park, Sonya
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [32] Diagnostic Value of FDG-PET/CT for the Identification of Extranodal Extension in Patients With Head and Neck Squamous Cell Carcinoma
    Toya, Ryo
    Saito, Tetsuo
    Matsuyama, Tomohiko
    Kai, Yudai
    Shiraishi, Shinya
    Murakami, Daizo
    Yoshida, Ryoji
    Watakabe, Takahiro
    Sakamoto, Fumi
    Tsuda, Noriko
    Arimura, Hidetaka
    Orita, Yorihisa
    Nakayama, Hideki
    Oya, Natsuo
    [J]. ANTICANCER RESEARCH, 2020, 40 (04) : 2073 - 2077
  • [33] Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma: Association with Metabolic Tumor Burden Determined with FDG-PET/CT
    Silvoniemi, Antti
    Laine, Jukka
    Aro, Katri
    Nissi, Linda
    Back, Leif
    Schildt, Jukka
    Hirvonen, Jussi
    Hagstrom, Jaana
    Irjala, Heikki
    Aaltonen, Leena-Maija
    Seppanen, Marko
    Minn, Heikki
    [J]. CANCERS, 2023, 15 (15)
  • [34] Phase 2a Study of Cetuximab and Dasatinib in Patients With Cetuximab-Resistant Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
    Geiger, J. L.
    Egloff, A. M.
    Ohr, J.
    Stabile, L.
    Gooding, W.
    Flaherty, J.
    Gibson, M.
    Grandis, J.
    Bauman, J. E.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 94 (04): : 930 - 930
  • [35] Phase II Study of Saracatinib (AZD0530) for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)
    Fury, Matthew G.
    Baxi, Shrujal
    Shen, Ronglai
    Kelly, Katherine W.
    Lipson, Brynna L.
    Carlson, Diane
    Stambuk, Hilda
    Haque, Sofia
    Pfister, David G.
    [J]. ANTICANCER RESEARCH, 2011, 31 (01) : 249 - 253
  • [36] Phase II study of combination cisplatin, docetaxel and erlotinib in patients with metastatic/recurrent head and neck squamous cell carcinoma (HNSCC).
    Kim, E. S.
    Kies, M. S.
    Glisson, B. S.
    Ginsberg, L. E.
    Holsinger, F. C.
    Burke, B. J.
    Truong, M.
    Tsao, A. S.
    Hong, W. K.
    Lippman, S. M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 285S - 285S
  • [37] A randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neck
    Seiwert, T. Y.
    Fayette, J.
    Cupissol, D.
    del Campo, J. M.
    Clement, P. M.
    Hitt, R.
    Degardin, M.
    Zhang, W.
    Blackman, A.
    Ehrnrooth, E.
    Cohen, E. E. W.
    [J]. ANNALS OF ONCOLOGY, 2014, 25 (09) : 1813 - 1820
  • [38] Phase II study of pemetrexed in combination with cisplatin and cetuximab in recurrent or metastatic squamous cell carcinoma of the head and neck
    Vermorken, J. B.
    Licitra, L.
    Stoehlmacher-Williams, J.
    Dietz, A.
    Lopez-Picazo, J. M.
    Hamid, O.
    Hossain, A. M.
    Chang, S. -C.
    Gauler, T. C.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 (13) : 2877 - 2883
  • [39] 18F-FDG-PET/CT for the Assessment of the Contralateral Neck in Patients with Head and Neck Squamous Cell Carcinoma
    Kastrinidis, Nikos
    Kuhn, Felix P.
    Hany, Thomas F.
    Ahmad, Nader
    Huber, Gerhard F.
    Haerle, Stephan K.
    [J]. LARYNGOSCOPE, 2013, 123 (05): : 1210 - 1215
  • [40] Systematic FDG-PET/CT for the detection of recurrent head and neck squamous cell carcinoma 6 months after curative treatment
    Balogova, S.
    Xu, Y.
    Perie, S.
    Kerrou, K.
    Huchet, V.
    Montravers, F.
    Pascal, O.
    Vercellino, L.
    St Guily, J. Lacau
    Talbot, J.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S184 - S184
12345